BioNTech
BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases. The company utilizes technology platforms including mRNA-based... Wikipedia
- Type: Public company
- Traded as: NASDAQ: BNTX
- ISIN: [ ISIN: [ US09075V1026]]
- Industry: Biotechnology
- Founded: 2008
- Founders: Uğur Şahin, Özlem Türeci, Christoph Huber
- Number of locations: 26(2026)
- Area served: Worldwide
- Key people: Uğur Şahin (CEO), Annemarie Hanekamp (CCO), Kylie Jimenez (CPO), Sierk Pötting (COO), James Ryan (CLO, CBO), Özlem Türeci (CMO), Ramón Zapata (CFO)
- Products: Pfizer-BioNTech COVID-19 vaccine, Immunotherapy and vaccine candidates
- Services: Immunotherapy
- Revenue: €2.87 billion(2025)
- Operating income: €−1.40 billion(2025)
- Total assets: €21.99 billion(2025)
- Total equity: €19.22 billion(2025)
- Number of employees: 7,807(2025)
- Website: biontech.com
- Data source: DuckDuckGo